 "GMM Pfaudler hit record high; surges 55% in five months")
Shares of GMM Pfaudler rallied 9% to Rs 1,247 apiece on Friday, extending their 4% gain on Thursday on the BSE in an otherwise range-bound market on expectations of strong earnings growth.
The stock of capital goods company was trading at its record high level, it has rallied 55% in the past five months. In comparison, the S&P BSE Sensex was down 1% during the same period.
GMM Pfaudler is a leading supplier of process equipment to the pharmaceutical and chemical industries. The company had reported a healthy 50% year-on-year (y-o-y) growth in net profit at Rs 189 million for H1FY19 (April-September). Operating revenue grew 32% at Rs 1,924 million on y-o-y basis. Ebitda (earnings before interest, tax, depreciation and amortization) margin expanded 300 bps at 16% in H1FY19 from 13% in H1FY18.
The key demand industries for GMM Pfaudler - pharmaceuticals, specialty chemicals and agrochemicals, are all expected to grow at a CAGR of 10-15% over the next 5 years. These industries will continue to invest to increase their manufacturing capacity as well as to upgrade their manufacturing facilities.
“Demand outlook across our business lines remain buoyant and our backlog continues to be very strong across all our business lines driven by the chemical and pharmaceutical sectors. Exports sales have been steadily improving and we are also seeing improved performance in our subsidiary Mavag,” Tarak Patel, Managing Director, GMM Pfaudler said while announcing September quarter results.
Looking at the positive economic momentum and the initiatives taken by the Indian Government, our end user industries will witness capital spending for both new manufacturing facilities as well as upgrading of existing facilities. India stands at an inflection point to benefit from the global supply shortage in the specialty chemical segment and strong domestic drivers in the pharmaceutical and agro chemical segment, the company said in an annual report.
At 10:32 am; GMM Pfaudler was trading 9% higher at Rs 1,240 on the BSE. In comparison, the S&P BSE Sensex was unchanged at 35,925 levels. A combined around 14,000 shares changed hands on the counter on the BSE and NSE so far.
The stock of capital goods company was trading at its record high level, it has rallied 55% in the past five months. In comparison, the S&P BSE Sensex was down 1% during the same period.
GMM Pfaudler is a leading supplier of process equipment to the pharmaceutical and chemical industries. The company had reported a healthy 50% year-on-year (y-o-y) growth in net profit at Rs 189 million for H1FY19 (April-September). Operating revenue grew 32% at Rs 1,924 million on y-o-y basis. Ebitda (earnings before interest, tax, depreciation and amortization) margin expanded 300 bps at 16% in H1FY19 from 13% in H1FY18.
The key demand industries for GMM Pfaudler - pharmaceuticals, specialty chemicals and agrochemicals, are all expected to grow at a CAGR of 10-15% over the next 5 years. These industries will continue to invest to increase their manufacturing capacity as well as to upgrade their manufacturing facilities.
“Demand outlook across our business lines remain buoyant and our backlog continues to be very strong across all our business lines driven by the chemical and pharmaceutical sectors. Exports sales have been steadily improving and we are also seeing improved performance in our subsidiary Mavag,” Tarak Patel, Managing Director, GMM Pfaudler said while announcing September quarter results.
Looking at the positive economic momentum and the initiatives taken by the Indian Government, our end user industries will witness capital spending for both new manufacturing facilities as well as upgrading of existing facilities. India stands at an inflection point to benefit from the global supply shortage in the specialty chemical segment and strong domestic drivers in the pharmaceutical and agro chemical segment, the company said in an annual report.
At 10:32 am; GMM Pfaudler was trading 9% higher at Rs 1,240 on the BSE. In comparison, the S&P BSE Sensex was unchanged at 35,925 levels. A combined around 14,000 shares changed hands on the counter on the BSE and NSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%